Show simple item record

Improving the Rate of Admission MRSA Screening and Intervention

dc.contributor.authorEjiofor-Okoli, Joan
dc.contributor.authorGourley, Bridgitte
dc.contributor.authorMurray, Jean
dc.date.accessioned2022-03-21T17:22:29Z
dc.date.available2022-03-21T17:22:29Z
dc.date.issued2022-03
dc.identifier.urihttp://hdl.handle.net/10713/18309
dc.description.abstractMethicillin Resistant Staphylococcus Aureus (MRSA) is a leading cause of hospital acquired infection (HAI) and healthcare associated pneumonia (HCAP) which results in poor patient outcomes including increased length of stay, morbidity, cost, and mortality. Screening and testing newly admitted patients for MRSA colonization or infection, and providing treatment, are effective management strategies in combating MRSA infections in hospitalized patients.en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshMethicillin-Resistant Staphylococcus aureusen_US
dc.subject.meshStaphylococcal Infections--prevention & controlen_US
dc.subject.meshInfection Control--methodsen_US
dc.subject.meshReminder Systemsen_US
dc.titleImproving the Rate of Admission MRSA Screening and Interventionen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-03-21T17:22:30Z


Files in this item

Thumbnail
Name:
SON_Ejiofor-Okoli_2022.pdf
Size:
392.1Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International